BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 32638371)

  • 1. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.
    Wang J; Li S; Liu Y; Zhang C; Li H; Lai B
    Cancer Med; 2020 Jan; 9(1):361-373. PubMed ID: 31693304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study.
    van den Berg I; van de Weerd S; Roodhart JML; Vink GR; van den Braak RRJC; Jimenez CR; Elias SG; van Vliet D; Koelink M; Hong E; van Grevenstein WMU; van Oijen MGH; Beets-Tan RGH; van Krieken JHJM; IJzermans JNM; Medema JP; Koopman M;
    BMC Cancer; 2020 Aug; 20(1):776. PubMed ID: 32811457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?
    Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC
    Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in stage 1 colon cancer: Patient characteristics and survival analysis from the national cancer database.
    Hsu AT; Wolf JH; D'Adamo CR; Felton J; Paul S; Kumar P; Mavanur AA
    Surg Oncol; 2024 Jun; 54():102075. PubMed ID: 38636304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial).
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsui S; Teramukai S; Murotani K; Ajioka Y; Shimazaki H; Maeda A; Takuma K; Yoshida T; Kambara T; Matsuda K; Takagane A; Tomita N; Sugihara K;
    Am J Surg Pathol; 2020 Dec; 44(12):1685-1698. PubMed ID: 32868525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of perineural invasion on survival in node negative colon cancer.
    Mirkin KA; Hollenbeak CS; Mohamed A; Jia Y; El-Deiry WS; Messaris E
    Cancer Biol Ther; 2017 Sep; 18(9):740-745. PubMed ID: 28475454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in the management of stage II colon cancer.
    Dotan E; Cohen SJ
    Semin Oncol; 2011 Aug; 38(4):511-20. PubMed ID: 21810510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites.
    Tan C; Wang Q; Yao S
    Am J Clin Oncol; 2024 Jun; 47(6):253-258. PubMed ID: 38251762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis.
    Oh SY; Kim CW; Kim S; Kim MH; Kim YI; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS
    Clin Colorectal Cancer; 2024 Jun; 23(2):135-146.e3. PubMed ID: 38749791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to stage-specific treatment guidelines for patients with colon cancer.
    Chagpar R; Xing Y; Chiang YJ; Feig BW; Chang GJ; You YN; Cormier JN
    J Clin Oncol; 2012 Mar; 30(9):972-9. PubMed ID: 22355049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in management and outcomes of colon cancer in the United States over 15 years: Analysis of the National Cancer Database.
    Horesh N; Emile SH; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    Int J Cancer; 2024 Jul; 155(1):139-148. PubMed ID: 38454540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.
    Mohamed A; Jiang R; Philip PA; Diab M; Behera M; Wu C; Alese O; Shaib WL; Gaines TM; Balch GG; El-Rayes BF; Akce M
    Front Oncol; 2021; 11():755113. PubMed ID: 34760701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marriage is a dependent risk factor for mortality of colon adenocarcinoma without a time-varying effect.
    Liu M; Li L; Yu W; Chen J; Xiong W; Chen S; Yu L
    Oncotarget; 2017 Mar; 8(12):20056-20066. PubMed ID: 28423614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Real-World Evidence for Treatment Selection: A Case Study in Colon Cancer.
    Shen L; van Gestel A; Prinsen P; Vink G; van Erning FN; Geleijnse G; Kaptein M
    JCO Clin Cancer Inform; 2024 May; 8():e2300186. PubMed ID: 38753347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer.
    Zhu E; Zhang L; Wang J; Hu C; Pan H; Shi W; Xu Z; Ai P; Shan D; Ai Z
    Breast Cancer Res Treat; 2024 May; 205(1):97-107. PubMed ID: 38294615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Historical Housing Discrimination and Colon Cancer Treatment and Outcomes in the United States.
    Hussaini SMQ; Fan Q; Barrow LCJ; Yabroff KR; Pollack CE; Nogueira LM
    JCO Oncol Pract; 2024 May; 20(5):678-687. PubMed ID: 38320228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer.
    Budinská E; Čarnogurská M; Ivković TC; Macháčková T; Boudná M; Pifková L; Slabý O; Bencsiková B; Popovici V
    Front Oncol; 2024; 14():1367231. PubMed ID: 38706608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.
    Petrelli F; Rulli E; Labianca R; Lonardi S; Rosati G; Dotti K; Ronzoni M; Pella N; Pusceddu V; Banzi M; Zampino MG; Yasmina M; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Zagonel V; Maiello E; Sobrero A;
    Ann Oncol; 2021 Jan; 32(1):66-76. PubMed ID: 33098997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Shaib WL; Zakka KM; Jiang R; Yan M; Alese OB; Akce M; Wu C; Behera M; El-Rayes BF
    Cancer; 2020 Sep; 126(18):4136-4147. PubMed ID: 32697360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.